PHARMACYTE BIOTECH, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-01-31 was $1.65M.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-07-31 was $70.00, a 92.05% decline year-over-year.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-07-31 was $880.00.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, stock options exercised for fiscal 2026 was $1.65M.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $70.00, a 92.05% decline from fiscal 2023.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $880.00.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-04-30 | $1.65M 10-K · filed 2026-07-29 | |
| 2026-01-31 | $1.65M 10-Q · filed 2026-03-17 | |
| 2024-04-30 | $70.00 10-K · filed 2024-08-13 | |
| 2023-07-31 | $70.00 10-Q · filed 2024-03-18 | |
| 2023-04-30 | $880.00 10-K · filed 2024-08-13 | |
| 2022-07-31 | $880.00 10-Q · filed 2024-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |